The Pharma Data

JANUARY 25, 2021

With a mandate to serve patients and an emphasis on public health, CSL Behring is a co-founder of the CoVIg-19 Plasma Alliance , which aims to develop an anti-coronavirus hyperimmune globulin (H-Ig) made from a convalescent plasma for the treatment of hospitalized adults at risk for serious complications of COVID-19. “It

Antibody 52

Antibody Trials Vaccination Vaccine 52

The Pharma Data

DECEMBER 3, 2020

The TAK-620-303 (SOLSTICE) trial (NCT02931539) is a multicenter, randomized, open-label, active-controlled trial comparing eight weeks of treatment with either maribavir or investigator assigned treatment (IAT) in transplant recipients with CMV infection refractory or resistant to existing antiviral treatments (i.e., About Maribavir.

Drugs 52

Drugs Medicine Trials Containment 52

The Pharma Data

JANUARY 26, 2021

The PRESECO study aims to determine the efficacy of Avigan as an early treatment for COVID-19 patients with mild-to-moderate symptoms, with the goal of alleviating symptoms and preventing disease progression before the infection requires hospitalizations or other intensive interventions. Dr. Reddy’s operates in markets across the globe.

Life Science 40

Life Science Production Marketing Dermatology 40

The Pharma Data

OCTOBER 29, 2020

AA is an autoimmune disorder that can cause unpredictable hair loss on the scalp, face and other areas of the body. In the Phase 2 portion, the most common adverse event was upper respiratory tract infection which occurred in 17.9%, 11.1% WARNING: SERIOUS INFECTIONS, MALIGNANCY, AND THROMBOSIS. versus placebo).

Dermatology 52

Dermatology Development Medicine Clinical Trials 52

Roots Analysis

JANUARY 23, 2024

It is worth mentioning that over the span of years, the pharmaceutical companies have shifted their focus from conventional interventions towards more advanced pharmacological strategies, such as peptide therapeutics. The peptide therapeutics market has undergone substantial evolution since the inception of insulin.

Development 40

Development Contract Manufacturing Drugs Manufacturing 40

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca. “The

Pharma Companies 113

Pharma Companies Sales Vaccination Vaccine 113

The Pharma Data

NOVEMBER 19, 2020

Structure-based design approach has identified potent compounds for further development as oral treatments for SARS-CoV-2 infection and related human coronaviruses. Sosei Heptares has successfully designed three distinct series of compounds with attractive anti-viral drug-like properties and advanced the most promising molecules.

Development 40

Development Bioavailability Production Drugs 40

Pharmaceutical Technology

FEBRUARY 15, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry. Boehringer Sohn.

DNA 130

DNA Antibody Vaccination Vaccine 130

XTalks

JANUARY 5, 2021

In other research areas, innovations in the pharmaceutical, medical device and biotech industries will benefit from approaches such as artificial intelligence (AI) and increased digitization. DCTs will continue to be a focus in the coming year as more and more trials go virtual or hybrid, and this will likely transcend the pandemic.

Life Science 98

Life Science Clinical Trials Clinical Trials Trials 98

XTalks

DECEMBER 4, 2020

Since CKD is a broad diagnosis that can have a variety of underlying causes, a beneficial focus of current research strategies has been to identify biomarkers and develop diagnostics that can help stratify patients into clinically relevant categories and help guide their management. GFR adjusted for body surface area (BSA).

Trials 52

Trials Clinical Trials Clinical Trials Antibody 52

The Pharma Data

JULY 29, 2021

Looking forward, we remain highly confident in our ability to achieve at least a 6% compound annual growth rate through 2025 and intend to build upon our recent successes by continuing to follow the science, trust in our people and remain focused on delivering breakthroughs for the patients we serve.”.

Manufacturing 52

Manufacturing Sales Contract Manufacturing Vaccination 52

XTalks

DECEMBER 13, 2023

This vaccine is designed to prevent infections caused by all known subtypes of the hepatitis B virus in adults aged 18 and older. Fulgent Genetics continues to make strides in its core genetics business, maintaining momentum in three primary areas: precision diagnostics, anatomic pathology and pharmaceutical services. million and $18.0

Genetics 111

Genetics Vaccination Vaccine DNA 111

Pharmaceutical Technology

AUGUST 26, 2008

It was once derided as the stuff of science fiction, but in recent years, biotechnology has emerged as an important growth area in pharmaceuticals. According to Staples, Protherics’ focus is not on technology per se but very much on products and particularly those which fit with its focus on critical care and cancer.

Antibody 130

Antibody Licensing Licensing Production 130

pharmaphorum

DECEMBER 14, 2022

As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and life sciences companies that drive healthcare innovation and improve patient experiences. It aims to shape companies in the digital healthcare, connected medical devices, and life sciences spaces.

Life Science 104

Life Science Development Business Development Genetics 104

XTalks

AUGUST 2, 2023

Join us as we present an in-depth analysis of each company’s revenue, net income, R&D investments, core therapeutic areas, market presence and strategic collaborations. In the third quarter of 2022, the company underwent several more organizational changes to better leverage expertise in key areas. Both are anti-CD20 agents.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

DECEMBER 23, 2020

LYT-100 is an anti-fibrotic and anti-inflammatory oral small molecule that has been designed to overcome the tolerability challenges associated with pirfenidone, an anti-inflammatory, anti-fibrotic drug currently on the market. Chen, told BioSpace that the company expects results in the second half of 2021.

Trials 52

Trials Clinical Trials Clinical Trials Drugs 52

XTalks

JUNE 12, 2023

In Medtronic’s annual report, CEO Geoff Martha attributes their success in this area to their comprehensive suite of products and solutions, which equip clinicians with the tools necessary for optimal atrial fibrillation care. This acquisition bolstered Medtronic’s position in the domain of cardiac ablation solutions.

FDA Approval 98

FDA Approval Production Sales In-Vitro 98

Pfizer

OCTOBER 28, 2022

1,2,3 As the developer of tofacitinib, Pfizer is committed to advancing the science of Janus kinase inhibition and enhancing understanding of tofacitinib through robust clinical development programs in the treatment of immune-mediated inflammatory conditions. SERIOUS INFECTIONS.

Clinical Trials 40

Clinical Trials Clinical Trials Vaccination Vaccine 40

XTalks

NOVEMBER 19, 2021

Richard Lee, MD, senior medical director in the medical department at Medpace, and board-certified in cardiothoracic surgery, explains how the focus of cardiac biomarkers has been primarily on their use as diagnostic tools. This also becomes important as cardiac biomarkers are being used in other therapeutic areas.

Clinical Trials 98

Clinical Trials Clinical Trials Trials In-Vitro 98

The Pharma Data

DECEMBER 29, 2020

In addition, the biochemical properties of the nanoparticles allow for easy adaptation to a format that facilitates the identification of infected individuals by sensitive and rapid virus detection in saliva and nasopharyngeal swabs.

Antibody 52

Antibody In-Vitro Engineer Development 52

XTalks

JANUARY 19, 2024

billion influx into radiopharmaceuticals which underscores the potential and robust growth in this therapeutic area. Tumors often contain areas with low oxygen levels (hypoxia), which are more resistant to radiation. In 2023, there have been pivotal trends shaping the landscape and application of alpha emitter therapy.

DNA 66

DNA Radiology FDA Approval Development 66

Drug Discovery World

MAY 4, 2023

Ehrlich proved that magic bullets existed with Salvarsan, an anti-syphilis compound that cured a rabbit with a single dose and left it unharmed. Apart from this, there are a large number of diseases that are caused as complications of the primary microbial infection. Here started the story of drug discovery.

Medicine 52

Medicine Protein Drugs Bioassay 52

The Pharma Data

OCTOBER 27, 2020

“Novartis remains unwavering in its support for tackling COVID-19 and it is clear that this pandemic calls for not just scientific solutions, but also for collaboration between companies to provide treatments in an area of high unmet need. About Molecular Partners’ anti-COVID-19 program. About DARPin® therapeutics.

Development 52

Development Protein Manufacturing Medicine 52

The Pharma Data

JUNE 16, 2021

Tofacitinib should not be used in patients with an active serious infection. It is important to note that tofacitinib has not been approved or authorized for use by any regulatory authority worldwide for the treatment of COVID-19 and tofacitinib should not be used in patients with an active serious infection. to 0.97; p=0.04).

Medicine 40

Medicine Clinical Trials Clinical Trials Trials 40

The Pharma Data

SEPTEMBER 15, 2020

Company has 89 pipeline projects spread across 6 targeted therapeutic areas with 4 programs in registration and 23 in Phase 3. Based on current infection rates, the companies continue to expect that a conclusive readout on efficacy is likely by the end of October. THERAPEUTIC AREAS OF FOCUS. Protease Inhibitor Program.

Gene Therapy 52

Gene Therapy Vaccination Vaccine Trials 52

The Pharma Data

DECEMBER 15, 2020

Many drug makers are investing in new science and hope to develop new therapeutics that address autoimmune disease. Anti-CD40L Antibody. The cause of many of the diseases is unknown. . BioSpace has captured some key efforts. Inflammatory Overreaction. There are approximately 1.5 Receptor Inhibitors.

Clinical Trials 52

Clinical Trials Clinical Trials Antibody Trials 52

Drug Discovery World

JUNE 6, 2023

An internationally recognised leader in the field of cancer immunobiology, Greenberg has made groundbreaking contributions to examining host T-cell responses to pathogenic viral infections and cancers. DDW spoke with Allan Jordan, Vice President of Oncology Drug Discovery at Sygnature Discovery at this year’s AACR meeting in Orlando.

Protein 52

Protein DNA RNA Research 52

The Pharma Data

FEBRUARY 8, 2021

In our commitment to advance the science and treatment of prostate cancer, these findings will help inform our research efforts in developing novel approaches and combinatory regimens to improve outcomes for these patients.”. It is unknown whether anti-epileptic medications will prevent seizures with ERLEADA ®.

HR 52

HR In-Vitro Development Clinical Trials 52

The Pharma Data

MAY 15, 2021

I was literally unable to get up because even the slightest movement of the affected area was beyond unbearable. I started with the standard meds: anti-inflammatories, steroid jabs, drugs to reduce the uric acid in my blood…. Doctors all over America typically focus on three different approaches to the gout problem. Removing it.

Bacteria 52

Bacteria Doctors Doctor Production 52

The Pharma Data

APRIL 26, 2021

COVID-19 negatively impacted demand, particularly: dermatology, ophthalmology, the breast cancer portfolio, Sandoz Retail and Anti-Infectives. Underpinning our financial results in the quarter is a continued focus on key growth drivers including: Entresto. First quarter key growth drivers. About Novartis.

Sales 40

Sales Medicine Production Manufacturing 40

XTalks

DECEMBER 24, 2020

The pandemic propelled the life science and healthcare sectors onto center stage, and they rose to the occasion against the most unprecedented health challenge in recent times. The most positive thing to be gleaned from the pandemic is how it allowed for the power and pursuit of science to shine.

Life Science 111

Life Science Vaccination Vaccine Gene 111

The Pharma Data

MAY 4, 2021

Frank D’Amelio, Chief Financial Officer and Executive Vice President, Global Supply, stated: “I am very happy with the performance of all of our therapeutic areas this quarter. These assumptions are guided by the trajectory of current infection rates in many parts of the world and the expected timeline for broad access to effective vaccines.

Vaccination 40

Vaccination Vaccine Production Sales 40

XTalks

SEPTEMBER 14, 2020

These responses provided complete or near-complete protection in bronchoalveolar lavage and nasal swabs following SARS-CoV-2 challenge, suggesting that a single shot of the J&J candidate vaccine protected at least nonhuman primates against SARS-CoV-2 infection. times higher than those from previously infected patients.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92